Prediabetes in acute coronary syndrome: an overlooked predictor of adverse outcomes

Frontiers in Clinical Diabetes and Healthcare 2026 Open access

Read full text
Authors: Daniel Hakim, Louay Taha, Mohammad Karmi, Eyal Ben-Zvi, Asher Schnur, Rafael Hitter, Noam Fink, Pierre François Sabouret, Mamas A. Mamas, Ranim Aouda, Akiva Brin, Ari Naimark
+3 more Amjad Abu-Salman, Michael Glikson, Elad Asher
DOI: 10.3389/fcdhc.2026.1745724
Cited by: 0
References: 24

Abstract

Background: Hemoglobin A1c (HbA1c) is a well-established marker for long-term glycemic control and a diagnostic tool for diabetes mellitus (DM). The relationship between HbA1c levels and prognosis among acute coronary syndrome (ACS) patients is not well described. The aim of the current study was to assess HbA1c levels as an independent predictor of mortality in patients with ACS admitted to contemporary intensive cardiovascular care unit (ICCU). Methods: A retrospective single center study included all patients admitted to the ICCU between July 2019 and December 2024 with ACS. Patients were categorized by HbA1c levels into three groups: non-DM (

Fields of Study & Subjects

Acute Myocardial Infarction Research Diabetes Cardiovascular Risks and Lipoproteins Hyperglycemia and glycemic control in critically ill and hospitalized patients

Publication details

Journal / source
Frontiers in Clinical Diabetes and Healthcare
Volume
7
Pages
1745724–1745724
Publication date
12 March 2026
Language
EN